Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 29, 2000 - Issue 5
Submit an article Journal homepage
22
Views
2
CrossRef citations to date
0
Altmetric
Research Article

CPH 82 (Reumacon ) in refractory inflammatory arthritis

Elisabet S. Gudmundsdóttir, Helgi Jónsson Landspítalinn University Hospital, IS-101 Reykjavik, Iceland
Pages 323-325 | Published online: 12 Jul 2009

Reference

  • Larsen A, Petersson I, Svensson B. Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1989;28: 124–7.
  • Bjorneboe O, Moen F, Nygaard H, Haavik TK, Svensson B. CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA. Scand J Rheumatol 1998;27: 26–31.
  • Lerndal T, Svensson B. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Rheumatology 2000;39:316–20.
  • Rantapaa Dahlqvist S, Landberg G, Roos G, Norberg B. Cell cycle effects of the anti-rheumatic agent CPH 82. Br J Rheumatol. 1994;33:327–31.
  • Truedsson L, Geborek P, Sturfelt G. Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82). Clin Exp Rheumatol 1993;11: 179— 82.
  • Dahlqvist SR, Olsson T. Interference with the cortisol axis by the microtubule antagonist, CPH 82. Br J Rheumatol 1993;32:804–6.
  • Magnusson S. Corticosteroid effect of CPH 82. Scand J Rheumatol. 1993;22:136–7.
  • Carlstrom K, Hedin PJ, Jonsson L, Lemdal T, Lien J, Weitoft T, et al. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with Rheumatoid arthritis. Scand J Rheumatol 2000;29:89–94.
  • Jónsson H, Steinsson K. International letter: Rhematology in Iceland. Br J Rheumatol 1997;36:577 — 9.
  • Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheuma-tol 1990;17: 994— 1002.
  • Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clin Rheumatol 1995;9:619— 32.
  • Gestel AM, Haagsma CJ, Furst DE, van Riel PLCM. Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs. Baillieres Clin Rheumatol 1997;11:65–82.
  • Korpela M, Tiitinen S, Nissila M. CPH 82 versus azathioprine in the treatment of rheumatoid arthritis and reactive (AA) amyloidosis. Abstract No. 888, June 1999, EULAR, Glasgow, Scotland.
  • Kwoh K, Anderson LG, Erlandson DM, et al. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.